Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06555289 · ClinicalTrials.gov registry record

Outcomes of Clareon PanOptix Pro in Patients With Prior Myopic Refractive Surgery

A clinical trial of Cataract, sponsored by Juliette Eye Institute Research Center.

Recruiting
Registry status
40
Enrollment target
1
Study location

NCT06555289 is a study of Cataract that is actively recruiting participants, run by Juliette Eye Institute Research Center. The registered enrollment target is 40 participants, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06555289, a study of Cataract, is actively recruiting participants, sponsored by Juliette Eye Institute Research Center.

RECRUITING
Registry status
40 participants
Enrollment target
1
Study location

Study Summary

This study is a Single center, single arm, prospective, observational study of clinical outcomes following bilateral cataract surgery and Clareon PanOptix Pro implantation. Subjects will be assessed preoperatively, and at 1 and 3 months postoperatively. Clinical evaluations will include administration of the QUVID and IOLSAT questionnaires, manifest refraction, topography, as well as measurement of visual acuities at distance, intermediate, and near.

Conditions Studied

Interventions

  • DEVICE Clareon PanOptix Pro IOL

Study Locations (1)

New Mexico

  • Juliette Eye Institute Research Center - Albuquerque

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2024-10-23
Est. Completion 2026-09-01

What the Registry Record Tells You About NCT06555289

The ClinicalTrials.gov registry entry for NCT06555289 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (82% lower). The listed sponsor is Juliette Eye Institute Research Center, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cataract appearing as the primary indexed condition, and to 1 intervention - of which Clareon PanOptix Pro IOL is the first listed.

NCT06555289 reports 1 study location spanning 1 distinct geographic area - top geographies include New Mexico.

Frequently Asked Questions

What is clinical trial NCT06555289 about?

NCT06555289 is a clinical study titled "Outcomes of Clareon PanOptix Pro in Patients With Prior Myopic Refractive Surgery". This study is a Single center, single arm, prospective, observational study of clinical outcomes following bilateral cataract surgery and Clareon PanOptix Pro implantation. Subjects will be assessed preoperatively, and at 1 and 3 months postoperatively. Clinical evaluations will include administrati...

What is the current status of trial NCT06555289?

This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2024-10-23. Estimated completion is 2026-09-01.

What conditions does trial NCT06555289 study?

This clinical trial studies the following conditions: Cataract.

What interventions are being tested in trial NCT06555289?

The interventions under investigation include: Clareon PanOptix Pro IOL (DEVICE).

Who is sponsoring clinical trial NCT06555289?

This trial is sponsored by Juliette Eye Institute Research Center, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06555289 being conducted?

This trial has 1 study location across New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cataract

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.